JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules

/PRNewswire/ -- JanOne (Nasdaq: JAN) (the "Company"), a biopharmaceutical company specializing in developing non-addicting pain killers and treatments for...

Related Keywords

United States , New York , , Nasdaq , Exchange Commission , Janone Inc , Hc Wainwright Co , Securities Act , Private Securities Litigation Reform Act ,